Skip to main content
Premium Trial:

Request an Annual Quote

Van Andel Starts Translational Cancer Program

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Van Andel Research Institute (VARI) has started a new pediatric cancer research program that will focus on using molecular analysis and personalized medical approaches, VARI said today.

The VARI Pediatrics Cancer Translational Research Program will use genomic techniques to develop treatments for children with cancer.

The program will be led by pediatric oncologist Giselle Sholler, who currently is chair of the Neuroblastoma and Medulloblastoma Translational Research Consortium, and by co-director Craig Webb, who also is director of VARI's Program of Translational Medicine.

"This new initiative is undertaken with the best objective that I can possibly imagine: the goal of curing children with cancer," VARI Chairman and CEO David Van Andel said in a statement.

Grand Rapids, Mich.-based VARI said that the new program will enable large-scale projects using genomics and molecular analysis techniques to identify the best treatment options based on the individual tumor biology.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.